|
1.
|
Nakamura T, Yamazaki Y, Saiki Y, Moriyama
M, Largaespada DA, Jenkins NA and Copeland NG: Evi9 encodes a novel
zinc finger protein that physically interacts with BCL6, a known
human B-cell proto-oncogene product. Mol Cell Biol. 20:3178–3186.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Liu P, Keller JR, Ortiz M, et al: Bcl11a
is essential for normal lymphoid development. Nat Immunol.
4:525–532. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Satterwhite E, Sonoki T, Willis TG, et al:
The BCL11 gene family: involvement of BCL11 A in lymphoid
malignancies. Blood. 98:3413–3420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hystad ME, Myklebust JH, Bø TH, et al:
Characterization of early stages of human B cell development by
gene expression profiling. J Immunol. 179:3662–3671. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Martín-Subero JI, Gesk S, Harder L, et al:
Recurrent involvement of the REL and BCL11A loci in classical
Hodgkin lymphoma. Blood. 99:1474–1477. 2002.PubMed/NCBI
|
|
6.
|
Weniger MA, Pulford K, Gesk S, et al:
Gains of the proto-oncogene BCL11A and nuclear accumulation of
BCL11A(XL) protein are frequent in primary mediastinal B-cell
lymphoma. Leukemia. 20:1880–1882. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Liu H, Ippolito GC, Wall JK, et al:
Functional studies of BCL11A: characterization of the conserved
BCL11A-XL splice variant and its interaction with BCL6 in nuclear
paraspeckles of germinal center B cells. Mol Cancer. 5:182006.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Yin B, Delwel R, Valk PJ, Wallace MR, Loh
ML, Shannon KM and Largaespada DA: A retroviral mutagenesis screen
reveals strong cooperation between Bcl11a overexpression and loss
of the Nf1 tumor suppressor gene. Blood. 113:1075–1085. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gao Y, He D, Chen S, Yan X, Hu X and Li Y:
Quantitative detection of BCL11A gene expression B cell
malignancies by real-time RT-PCR. J Jinan Univ Med Ed. 32:147–150.
2011.(In Chinese).
|
|
10.
|
Gao Y, He D, Chen S, Yan X, Hu X and Li Y:
Expression of the B-cell lymphoma/leukemia 11A gene in malignant
hematological cell lines through quantitative reverse transcription
polymerase chain reaction. Clin Oncol Cancer Res. 8:242–246. 2011.
View Article : Google Scholar
|
|
11.
|
Kirkin V, Joos S and Zornig M: The role of
Bcl-2 family members in tumorigenesis. Biochim Biophys Acta.
1644:229–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
He D and Fang B: Small hairpin RNA
targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji
cells. Acta Biochim Biophys Sin. 41:131–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cioca DP, Aoki YJ and Kiyosawa K: RNA
interference is a functional pathway with therapeutic potential in
human myeloid leukemia cell lines. Cancer Gene Ther. 10:125–133.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Xu J, Sankaran VG, Ni M, Menne TF, Puram
RV, Kim W and Orkin SH: Transcriptional silencing of {gamma}-globin
by BCL11A involves long-range interactions and cooperation with
SOX6. Genes Dev. 24:783–798. 2010.
|
|
17.
|
Sankaran VG, Menne TF, Xu J, et al: Human
fetal hemoglobin expression is regulated by the developmental
stage-specific repressor BCL11A. Science. 322:1839–1842. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Huang X, Chen S, Shen Q, et al: Down
regulation of BCL11B expression inhibits proliferation and induces
apoptosis in malignant T cells by BCL11B-935-siRNA. Hematology.
16:236–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Grabarczyk P, Przybylski GK, Depke M, et
al: Inhibition of BCL11B expression leads to apoptosis of malignant
but not normal mature T cells. Oncogene. 26:3797–3810. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Karanam NK, Grabarczyk P, Hammer E, et al:
Proteome analysis reveals new mechanisms of Bcl11b-loss driven
apoptosis. J Proteome Res. 9:3799–3811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Li L, Leid M and Rothenberg EV: An early T
cell lineage commitment checkpoint dependent on the transcription
factor Bcl11b. Science. 329:89–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Huang X, Chen S, Shen Q, et al: Analysis
of the expression pattern of the BCL11B gene and its relatives in
patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol.
3:442010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Karlsson A, Nordigården A, Jönsson JI and
Söderkvist P: Bcl11b mutations identified in murine lymphomas
increase the proliferation rate of hematopoietic progenitor cells.
BMC Cancer. 7:1952007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Avram D, Fields A, Top KP, Nevrivy DJ,
Ishmael JE and Leid M: Isolation of a novel family of C(2)H(2) zinc
finger proteins implicated in transcriptional repression mediated
by chicken ovalbumin upstream promoter transcription factor
(COUP-TF) orphan nuclear receptors. J Biol Chem. 275:10315–10322.
2000. View Article : Google Scholar
|
|
25.
|
Biroccio A, Leonetti C and Zupi G: The
future of antisense therapy: combination with anticancer
treatments. Oncogene. 22:6579–6588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Xing XK, Li SJ, He JL and Chen Z:
Inhibition of hepatitis C virus replication by single and dual
small interfering RNA using an HCV-infected cell model. Biotechnol
Lett. 34:295–301. 2012. View Article : Google Scholar : PubMed/NCBI
|
